Product/Composition:- | Atazanavir & Ritonavir |
---|---|
Strength:- | 300 mg Atazanavir + 100 mg Ritonavir |
Form:- | Tablets |
Reference Brands:- | Evotaz®(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Atazanavir/Ritonavir Tablets (300/100 mg) are key antiretrovirals for HIV-1 treatment. Available via PharmaB2B from WHO-GMP and USFDA-approved suppliers, this fixed-dose combo ensures boosted efficacy and once-daily convenience. Ideal for global procurement, tenders, and HIV programs seeking compliant, cost-effective sourcing.
Atazanavir & Ritonavir Tablets are a fixed-dose antiretroviral combination used in the management of HIV-1 infection, with Ritonavir boosting Atazanavir’s effectiveness. Available in a 300 mg + 100 mg formulation, this once-daily therapy is WHO-recommended and USFDA-approved. On PharmaB2B platforms, global buyers can connect with GMP-certified manufacturers for bulk procurement of quality-assured Atazanavir/Ritonavir tablets. Ideal for hospitals, NGOs, government tenders, and HIV treatment programs, PharmaB2B simplifies sourcing of affordable, compliant ARVs. Partner with reliable suppliers to support uninterrupted access to essential HIV care in both regulated and emerging markets.